netFormulary NHS
Shropshire and Telford Local Health Economy
Shropshire, Telford and Wrekin CCG
Shrewsbury and Telford Hospitals NHS Trust
Robert Jones & Agnes Hunt Orthopaedic Hospital NHS Foundation Trust
Shropshire Community Health NHS Trust
 Search
 Formulary Chapter 2: Cardiovascular system - Full Chapter
02.08.02  Expand sub section  Oral anticoagulants
Apixaban
View adult BNF View SPC online
Formulary
Green
 
Link  NICE TA275: Apixaban for AF
   
Dabigatran
View adult BNF View SPC online
Formulary
Green
 
Link  NICE TA249: Dabigatran for Stroke prevention in AF
   
Edoxaban
View adult BNF View SPC online
Formulary
Green
 
Link  NICE TA355:Edoxaban for preventing stroke/systemic embolism in non‑valvular atrial fibrillation
   
Rivaroxaban
View adult BNF View SPC online
Formulary
Green
 
   
Warfarin
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
   
Acenocoumarol
View adult BNF View SPC online
Formulary
Amber
 
   
Phenindione
View adult BNF View SPC online
Formulary
Amber
 
   
Andexanet Alpha  (Ondexxya)
View adult BNF View SPC online
Restricted Drug Restricted
Red

To be used in MAU on advice from on call heamatologist

 
Link  NICE TA697: Andexanet alfa for reversing anticoagulation from apixaban or rivaroxaban
   
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Green

Suitable first-line drugs for implementation in Primary Care  

Amber

These medicines are considered suitable for prescribing in Primary Care following specialist (consultant or GPwSI) initiation or recommendation. Some of these medicines may require on-going communication between the Secondary Care specialist and the Primary Care prescriber using Prescribing Information (PI) or through the use of an Effective Shared Care Agreement (ESCA) and this will be indicated in the text.  

Red

Drugs which require special consideration. These are drugs for use in Secondary Care ONLY, Consultant Prescribing ONLY or by Tertiary Centres ONLY where indicated in the text. They should not be prescribed in Primary Care.  

Black

Medicines classified in the BNF as 'not NHS' or are considered by the Area Prescribing Committee to be of low clinical value should not be prescribed  

netFormulary